FDA APPROVES FIRST AI - POWERED RETINOPATHY APP: The US Food and Drug Administration (FDA) greenlit the marketing of IDx - DR, the first medical device that uses artificial intelligence (AI) to
detect diabetic retinopathy — a leading cause of blindness among people with diabetes.